Introducing the Science Behind Targeted Treatments and Immunotherapies for Non-small Cell Lung Cancer (NSCLC)
National Heart and Lung Institute, London, SW3 6LYDr Elaine Vickers, guides you through many of the most relevant topics relating to modern systemic treatments for non-small cell lung cancer (NSCLC). The morning’s focus is on the gene faults that drive many NSCLCs and on the targeted treatments that exploit these faults, such as inhibitors of EGFR, ALK, ROS1, B-Raf, HER2, MET and […]